Tag: TSXV: EMC

November 14, 2018

Canntab Corporate Update

Canntab Therapeutics (CSE:PILL) (“Canntab” or the “Company”) is a company with a clear vision of becoming the leader in solid...
September 18, 2018

Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials

Canntab Therapeutics (CSE:PILL) ("Canntab" or the "Company"), today announced the achievement of a milestone with regards to the development of...